Abstract:The high-mobility group box 1 (HMGB1) signaling pathway plays a crucial role in tumorigenesis and progression of many malignant cancers. The present study aimed to investigate the expression and clinical significance of HMGB1 in human primary liver cancer, and further explore the molecular mechanisms of HMGB1 in tumor growth and metastasis. Forty cases of human liver cancer and normal liver tissues were collected. The expression of HMGB1 was assessed using RT-PCR and western blot assays in biopsy samples. The HMGB1 pathway in vitro was blocked using transfection of the recombinant small hairpin RNA adenovirus vector rAd5-HMGB1 into the human liver cancer cell line SMMC-7721. The expression of HMGB1, phosphorylated AKT (p-AKT), Ki-67 and matrix metallopeptidase-2 (MMP-2) was detected by Real-PCR and western blot assays. Cell proliferative activities and metastatic capability were determined by MTT and Transwell assays. Cell cycle distribution and apoptosis were detected by flow cytometry. A subcutaneous xenograft tumor model was established, validating the effects of rAd5-HMGB1 on tumor growth in vivo. As a consequence, HMGB1 was found to be highly expressed in liver cancer compared with normal tissues, and was positively associated with pathological grade and distant metastases of liver cancer. Knockdown of HMGB1 downregulated the expression of p-AKT, Ki-67 and MMP-2, inhibited the proliferative activities and metastatic potential of SMMC-7721 cells, induced cell cycle arrest and apoptosis, and slowed the growth of xenograft tumors. Altogether, the expression of HMGB1 is closely correlated with pathological grade and distant metastases of liver cancer, and knockdown of HMGB1 inhibits liver cancer growth and metastasis, suggesting that HMGB1 may be involved in liver cancer development and progression through AKT-mediated regulation of Ki-67 and MMP-2 expression, and represent a potential therapeutic target for this aggressive malignancy.

HMGB1 Induces Human Non-Small Cell Lung Cancer Cell Motility by Activating Integrin Αvβ3/fak Through TLR4/NF-κB Signaling Pathway.

High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1

Retracted: HMGB1 Regulates SNAI1 During NSCLC Metastasis, Both Directly, Through Transcriptional Activation, and Indirectly, in a RSF1‐IT2‐dependent Manner

Exogenous HMGB1 Promoted Migration and Invasion of Breast Cancer Cells Through NFκB and MMP9

HMGB1 Promotes Lymphangiogenesis of Human Lymphatic Endothelial Cells in Vitro.

High-mobility Group Box 1: A Novel Inducer of the Epithelial–mesenchymal Transition in Colorectal Carcinoma

The Effect of HMGB1 on the Clinicopathological and Prognostic Features of Cervical Cancer.

High Mobility Group Box-1 Inhibits Cancer Cell Motility and Metastasis by Suppressing Activation of Transcription Factor CREB and Nwasp Expression.

High Mobility Group Box Protein 1 Serves As a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-κB-Dependent Manner

High‑mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma

High-mobility Group Box 1 Protein Activating Nuclear Factor-Κb to Upregulate Vascular Endothelial Growth Factor C is Involved in Lymphangiogenesis and Lymphatic Node Metastasis in Colon Cancer

The Role of HMGB1-RAGE Axis in Migration and Invasion of Hepatocellular Carcinoma Cell Lines

Long Non-Coding RNA UCA1 Promotes Lung Cancer Cell Proliferation and Migration Via Microrna-193A/hmgb1 Axis.

Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer

High Mobility Group Box 1 Promotes the Epithelial-to-mesenchymal Transition in Prostate Cancer PC3 Cells Via the RAGE/NF-κB Signaling Pathway

HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells.

The Activation of HMGB1 As a Progression Factor on Inflammation Response in Normal Human Bronchial Epithelial Cells Through RAGE/JNK/NF-κB Pathway

The Role of High-Mobility Group Protein Box 1 in Lung Cancer.

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration

Expression and Clinical Significance of HMGB1 in Human Liver Cancer: Knockdown Inhibits Tumor Growth and Metastasis in Vitro and in Vivo.